爱依斯(AES)
搜索文档
5 High-Yield Infrastructure Stocks Looking Cheap On The Dip
Seeking Alpha· 2025-01-04 20:05
The infrastructure sector ( UTF ) is poised for a boom in the coming years. Among the many factors driving this upward trajectory for the sector, perhaps the greatest is the growing need for clean and reliable electrical power. TheIf you want access to our Portfolios that have crushed the market since inception and all our current Top Picks, join us for a 2-week free trial at High Yield Investor.We are the fastest growing high yield-seeking investment service on Seeking Alpha with a perfect 5/5 rating from ...
Why AES (AES) is a Top Value Stock for the Long-Term
ZACKS· 2024-12-16 23:41
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor.Zacks Premium also includes the Zacks Style Scores. What are the Zacks Style Scores? The Zacks Style ...
3 Stocks to Keep an Eye on After Dividend Hike Announcement
ZACKS· 2024-12-12 22:25
The Wall Street rally appears to have paused after a month. Major indexes have retreated over the past few sessions after hitting record closing highs over the past month, as the post-election euphoria appears to be fizzling out.Also, geopolitical tensions coupled with concerns over the recent jump in inflation have somewhat dented investors’ confidence. Given this situation, cautious investors looking for a steady income and protecting their capital may look to hold or buy dividend-paying stocks.Three such ...
Here's Why AES (AES) is a Strong Momentum Stock
ZACKS· 2024-12-11 23:50
Zacks Premium服务 - Zacks Premium提供多种工具帮助投资者更自信地投资,包括每日更新的Zacks Rank和Zacks Industry Rank、Zacks 1 Rank List、股票研究报告和高级股票筛选器 [1] - Zacks Premium还包括Zacks Style Scores,这些评分帮助投资者选择在未来30天内可能跑赢市场的股票 [2][3] Zacks Style Scores - Zacks Style Scores基于价值、增长和动量特征,将股票评级为A、B、C、D或F,评分越高,股票表现越好的可能性越大 [3] - 价值评分关注市盈率、PEG比率、市销率、市现率等指标,帮助投资者发现被低估的股票 [4] - 增长评分分析公司未来的盈利、销售和现金流前景,寻找具有可持续增长潜力的股票 [5] - 动量评分利用一周价格变化和月度盈利预测变化等因素,帮助投资者把握高动量股票的买入时机 [6] - VGM评分结合价值、增长和动量评分,筛选出最具吸引力价值、最佳增长前景和最强劲动量的公司 [7] Zacks Rank与Style Scores的结合 - Zacks Rank通过盈利预测修订帮助投资者构建成功的投资组合,自1988年以来,1(强力买入)股票的平均年回报率为+25.41%,超过标普500指数的两倍 [8][9] - 投资者应选择Zacks Rank 1或2且Style Scores为A或B的股票,以最大化回报 [11] - 即使股票的Style Scores为A或B,如果Zacks Rank为4(卖出)或5(强力卖出),其盈利前景仍然可能下滑,股价也可能下跌 [12] - 持有更多Zacks Rank 1或2且Style Scores为A或B的股票,投资组合表现可能更好 [13] AES公司分析 - AES公司成立于1981年,是一家全球电力公司,业务遍布四大洲的14个国家,拥有260万客户,发电组合容量为34,596兆瓦 [14] - AES的Zacks Rank为3(持有),VGM评分为A,动量评分为B,过去四周股价上涨1.4% [15] - 过去60天内,三位分析师上调了AES 2024财年的盈利预测,Zacks共识估计增加了0.04美元至每股1.94美元,平均盈利惊喜为21.5% [15] - 凭借稳健的Zacks Rank和顶级的动量及VGM评分,AES应成为投资者的关注对象 [16]
My Top 2 Stock Picks For A 2025 Rebound
Seeking Alpha· 2024-12-11 22:32
核心观点 - 现在是投资股票的理想时机,主要因为税收损失出售导致的股票折扣[1] 投资策略 - 投资者专注于具有股息和价值股票的战略购买机会,这种策略在Tipranks.com上获得了接近5星的评级,并在Seeking Alpha上拥有超过9,000名关注者[1] 分析师披露 - 分析师持有AES和ATNM股票的长期受益头寸,包括通过股票所有权、期权或其他衍生品[1]
AES Announces Pricing of $500 Million Fixed-to-Fixed Reset Rate Junior Subordinated Notes in Public Offering
Prnewswire· 2024-12-05 05:30
ARLINGTON, Va., Dec. 4, 2024 /PRNewswire/ -- The AES Corporation (NYSE: AES) ("AES") announced today the pricing of $500 million aggregate principal amount of its 6.950% fixed-to-fixed reset rate junior subordinated notes due 2055 (the "Notes"). The closing of the offering of the Notes is expected to occur, subject to certain customary closing conditions, on December 6, 2024 (T+2).AES intends to use the net proceeds from the proposed offering to repay existing indebtedness, including borrowings under the re ...
NeuroPace to Showcase the RNS System at the 2024 American Epilepsy Society (AES) Annual Meeting
GlobeNewswire News Room· 2024-12-05 05:05
RNS System to be featured in over 70 scientific presentations and posters Pre-book a demonstration in the NeuroPace Tech Suite to see the latest innovations of the RNS System which simplify the treatment experience for physicians and patients NeuroPace’s Booth #2119 MOUNTAIN VIEW, Calif., Dec. 04, 2024 (GLOBE NEWSWIRE) -- December 4, 2024 – NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced that the Company will have a ...
AES Announces Public Offering of Fixed-to-Fixed Reset Rate Junior Subordinated Notes
Prnewswire· 2024-12-04 22:25
ARLINGTON, Va., Dec. 4, 2024 /PRNewswire/ -- The AES Corporation (NYSE: AES) ("AES") announced today its intention to offer, subject to market and other conditions, fixed-to-fixed reset rate junior subordinated notes (the "Notes") in a registered public offering.AES intends to use the net proceeds from the proposed offering to repay existing indebtedness, including borrowings under the revolving facility of its senior credit facility, and for general corporate purposes.J.P. Morgan Securities LLC, Wells Farg ...
Here's Why AES (AES) is a Strong Value Stock
ZACKS· 2024-11-29 23:40
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor.Zacks Premium includes access to the Zacks Style Scores as well. What are the Zacks Style Sco ...
Xenon to Showcase New Long-Term Azetukalner Data at AES 2024
GlobeNewswire News Room· 2024-11-25 21:30
Five posters to be presented including new long-term 36-month data from the ongoing X-TOLE OLE study of azetukalner in FOS and findings around mental health and comorbidity burdens of FOSNew pre-clinical data from the Company’s Nav1.1 program VANCOUVER, British Columbia and BOSTON, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics for patients in need, t ...